References
- Rabe KF, Hurd S, Anzueto A Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD. Am J Respir Crit Care Med 2007; 176:532–555.
- Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364:709–721.
- Birring SS, Brightling CE, Bradding P, Entwisle JJ, Vara DD, Grigg J, Wardlaw AJ, Pavord ID. Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: A descriptive study. Am J Respir Crit Care Med 2002; 166:1078–1083.
- Celli BR, Mac Nee W. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS Position Paper. Eur Respir J 2004; 23:932–946.
- Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: The role of the comorbidities. Eur Respir J 2006; 28:1245–1257.
- Rowley K, O'Dea K, Best JD. Association between albuminuria and the metabolic syndrome. Curr Diab Rep 2003; 3:80–86.
- Gibson GJ. Clinical Tests of Respiratory Function. 3rd ed. London: Hodder Arnold; 2009.
- Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008; 32:1371–1385.
- Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY, Large SR, Wells FC, Wallwork J. Impairment of endothelium dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med 1991; 324:1539–1547.
- Casanova C, de Torres JP, Navarro J, Aguirre-Jaíme A, Toledo P, Cordoba E, Baz R, Celli BR. Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182: 1004–1010.
- Komurcuoglu A, Kalenci S, Kalenci D, Komurcuoglu B, Tibet G. Microalbuminuria in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 2003; 59: 269–272.
- Polatli M, Cakir Q, Cildag O, Bolaman AZ, Yenisey C, Yenicerioglu Y. Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation. J Thromb Thrombol 2008; 26:97–102.
- Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global Strategy for The Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001; 163:1256–1276.
- American Thoracis Society. Standardization of spirometry. Statement of the American Thoracic Society. Am Rev Respir Dis 1987; 136:1285–1298.
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206–1252.
- American Thoracic Society. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111–117.
- Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54:581–586.
- Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005–1012.
- Jacobs DR Jr, Murtaugh MA, Steffes M, Yu X, Roseman J, Goetz FC. Gender- and racespecific determination of albumin excretion rate using albumin-tocreatinine ratio in single, untimed urine specimens. The study of coronary artery risk development in young adults. Am J Epidemiol 2002; 155: 1114–1119.
- Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, Mulsant B, Reynolds CF 3rd. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the cumulative illness rating scale. Psych Res 1992; 41:237–248.
- Afsar B, Elsurer R. The independent relationship between creatinine clearance, microalbuminuria and circadian blood pressure levels in newly diagnosed essential hypertensive and type 2 diabetic patients. J. Diabetes Complicat 2012 Jul 11 (Epub ahead of print).
- Nangaku M. Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17:17–25.
- Gogo A, Ciaccia A, Legorini C, Grimaldi A, Milani G. Proteinuria in COPD patients with and without respiratory failure. Chest 2003; 123:652–653.
- Hansen JM, Olsen NV, Feldt-Rasmussen B, Kanstrup IL, Déchaux M, Dubray C, Richalet JP. Albuminuria and overall capillary permeability of albumin in acute altitude hypoxia. J Appl Physiol 1994; 76:1922–1927.
- Gobal F, Deshmukh A, Shah S, Mehta JL. Triad of metabolic syndrome, chronic kidney disease, and coronary heart disease with a focus on microalbuminuria death by overeating. J Am Coll Cardiol 2011; 57:2303–2308.